CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project explores the use of photo-activatable drugs to treat epilepsy by enabling precise control over drug activation in targeted brain areas. By minimizing side effects and utilizing existing drugs in new ways, it aims to provide innovative therapeutic options for patients with intractable epilepsy.
As photo-activatable drugs (PDs) can be precisely controlled in space and time, caged and switchable photoactivatable drugs (CPDs, SPDs) are rapidly emerging as potential therapeutics for varied forms of cancer, vision loss, diabetes, or pain disorders.
Despite their potential, PDs have not been exploited for epilepsy, a common, often debilitating neurological disorder.
As 30% of epilepsies are medically intractable, and antiepileptic drugs often cause multi-organ side effects, PDs could break n…
UNIVERSITATSKLINIKUM BONN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
